#CART-cellTherapy
Creative Biolabs launches an AI-assisted CAR/TCR development platform integrating target discovery, construct engineering, and safety profiling to help researchers cut screening time and improve candidate selection. #CellTherapy #CART
October 9, 2026 at 5:47 PM
Explore how CAR-T analytics software , pipeline tracking and competitive intelligence can help biopharma teams understand clinical development, competitors and emerging in-vivo CAR-T opportunities in 2026.

Read: justpaste.it/h5rud

#CART #CellTherapy #Biotech #Pharma #Oncology
September 22, 2026 at 7:28 AM
🧪 A spatially resolved implantable #microdevice for multiplexed in situ screening of engineered cellular therapies in solid tumors | Science Advances
#cancer #biotech #CART #celltherapy
www.science.org/doi/10.1126/...
A spatially resolved implantable microdevice for multiplexed in situ screening of engineered cellular therapies in solid tumors
The clinical translation of cellular immunotherapies for solid tumors remains limited by the lack of adequate tools to evaluate therapeutic function within the native tumor microenvironment. Here, we ...
www.science.org
August 31, 2026 at 5:41 PM
Creative Biolabs has updated its in vivo CAR-T development portfolio, offering both viral and non-viral delivery options to support researchers tackling complex immune cell engineering challenges. Services are customizable for preclinical research programs. #CART #CellTherapy
August 27, 2026 at 11:04 AM
Our new open-access review is out in Trends in Biotechnology:

“Logic-gated CARs: a unified framework for programmable cell-based delivery systems”

Congratulations to our postdoc and students for their hard work!

doi.org/10.1016/j.ti...

#CellTherapy #SyntheticBiology #CART #Cell
August 11, 2026 at 10:02 PM
This means:

✅ Improved accuracy
✅ Better insights into CAR-T persistence
✅ More confidence in your data

Ready to see the difference?

Contact us at customer@immudex.com to learn more!

#CART #CARTTherapy #CellTherapy #Immunotherapy #FlowCytometry
February 18, 2025 at 8:53 AM
CAR-T cell therapy: A new dawn in the treatment of autoimmune disease
doi.org/10.1177/0963...
#CART #celltherapy #Immunotherapy
@journals.sagepub.com
January 28, 2026 at 8:37 AM
Join the ASTCT Pharmacy SIG on a discussion on Orca-T vs alloHCT and teclistamab plus daratumumab in r/r multiple myeloma. Register today: learn.astct.org/products/ast... #CART #celltherapy
March 3, 2026 at 10:03 PM
Highlights from the ASTCT Committee on Practice Guidelines session at #Tandem25.

➡️ Lack of access to #CART, concomitant therapy related to myeloid neoplasm or bone marrow failure syndrome. #bmtsm #mmsm #leusm #celltherapy
February 14, 2025 at 12:26 AM
ASTCT Committee on Practice Guidelines final clinical practice guidelines consensus statements for transplantation and #CART cell treatments for late first relapse, second relapse and beyond FL. #Tandem25 #celltherapy #OncSky #transplantation #leusm #bmtsm
February 14, 2025 at 12:10 AM
December 9, 2024 at 4:57 PM
Great starter pack for those of us In hematopoietic stem cell and T cell therapies. 💙🩵 #celltherapy #immunotherapy #genetherapy #CART
go.bsky.app/7xxh8WW
November 23, 2024 at 12:11 PM
So excited for #ASH24! Come see Emily Landy’s amazing work on human #iNKTCells biology so we can make better #celltherapy for cancer & fight #GVHD. Sat 12/12 at 5:30 Poster #1159 #iNKT #CART #CARTcells #immunity @ash-hematology.bsky.social @sitemancenter.bsky.social @washumedicine.bsky.social
December 5, 2024 at 11:37 PM
Excited to share our latest publication: CAR-T cells in colorectal cancer: Pioneering new avenues in solid tumor immunotherapy.
ascopubs.org/doi/10.1200/...
Journal of Clinical Oncology @ascocancer.bsky.social
#CART #CellTherapy @ascopost.bsky.social @oncoalert.bsky.social @oncodaily.bsky.social
January 15, 2025 at 7:36 PM
I am happy to share our new article in
@BloodJournal
. Acute myelopathy is a rare but devastating complication of CAR T-cell therapy: authors.elsevier.com/a/1k5wW1UYwn...

#CART #CellTherapy #Lymphoma #All
December 4, 2024 at 4:26 PM
Interesting discussion on the future of cell therapies at the #Genscript Healthcare Forum in London #celltherapy #CART $LGND
November 20, 2024 at 3:14 PM
CAR-T therapy may soon become more accessible in India. Vector BioMed and Kailash Cancer Hospital are working to deliver advanced cancer care at a lower cost.

#News #Interview #Exclusive #CART #CellTherapy #Oncology #CancerCare #Biotech #IndiaHealthcare
Vector BioMed pioneers affordable CAR-T cell therapies in India
The US-based company plans to deliver CAR-T cell therapies at low cost, with the first patients expected to receive therapy in 2026.
druganddeviceworld.com
August 26, 2025 at 7:38 AM
China’s NMPA has approved satricabtagene autoleucel, or satri-cel, for patients with Claudin18.2-positive, HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma after at least two prior lines of therapy.

Link in the comments 👇

#Oncology #CART #CellTherapy
June 29, 2026 at 4:44 PM
A new study published in @nature.com presents a strategy for generating CAR T cells directly in vivo, using site-specific genome engineering instead of traditional ex vivo manufacturing.

Link in the comments 👇

#Oncology #CART #CellTherapy #Immunotherapy #GenomeEditing
June 24, 2026 at 12:57 PM